KN
Keay Nakae Chardan Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
68
Avg Return
Past Year
Past Year
26%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Health Information Services
Medical Care Facilities
Medical Devices
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $20 |
360%
upside
| 1 | +3.8% |
0
%
| 12 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $14 |
263%
upside
| 2 | +18% |
0
%
| 11 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $38 |
90%
upside
| 2 | +16% |
0
%
| 9 Mar ‘26 1 month ago |
|
|
|
Buy
Upgraded
| $3 |
347%
upside
| 1 | -59% |
0
%
| 24 Feb ‘26 1 month ago |
|
|
|
Buy
Maintained
| $425 |
37%
upside
| 1 | +8.9% |
0
%
| 13 Feb ‘26 2 months ago |
|
|
|
Buy
Maintained
| $5 |
154%
upside
| 1 | +45% |
0
%
| 12 Feb ‘26 2 months ago |
|
|
|
Buy
Maintained
| $100 |
83%
upside
| 1 | +11% |
0
%
| 29 Jan ‘26 2 months ago |
|
|
|
Buy
Upgraded
| $15 |
5%
upside
| 1 | +31% |
0
%
| 29 Jan ‘26 2 months ago |
|